intravenous glucose tolerance test

BIOLOGICAL3 trials

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), German Diabetes Center, University of Alabama at Birmingham

Conditions

Cardiovascular DiseasesDiabetes MellitusEnergy ExpenditureInsulin Sensitivity/ResistanceMetabolic DiseaseMetabolic SyndromeMetabolismNatriuretic Peptides

Phase 2

NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals

RecruitingNCT04055428

University of Alabama at BirminghamCardiovascular Diseases, Diabetes Mellitus, Energy Expenditure +4

Start: 2020-08-15End: 2027-05-31Target: 200Updated: 2025-07-03

Unknown Phase

Insulin Sensitivity in Men With the Metabolic Syndrome

SuspendedNCT00433173

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Metabolic Syndrome

Start: 2006-05-31End: 2011-03-31Target: 72Updated: 2010-03-02

Assessment of Liver Glucose Metabolism in Diabetic Subjects

CompletedNCT01397279

German Diabetes CenterNewly Diagnosed Type 2 Diabetes (During the Last 12 Months)

Start: 2011-07-31End: 2013-12-31Updated: 2023-06-05

Related Papers

Estimates of insulin sensitivity from the intravenous-glucose-modified-clamp test depend on suppression of lipolysis in type 2 diabetes: a randomised controlled trial.

2014-07-2216 citations